4,298 Shares in National HealthCare Corporation $NHC Acquired by Summit Global Investments

Summit Global Investments purchased a new position in National HealthCare Corporation (NYSEAMERICAN:NHC) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,298 shares of the company’s stock, valued at approximately $908,000.

A number of other institutional investors have also added to or reduced their stakes in NHC. Royal Bank of Canada lifted its holdings in shares of National HealthCare by 53.6% in the first quarter. Royal Bank of Canada now owns 2,724 shares of the company’s stock worth $253,000 after buying an additional 950 shares in the last quarter. AQR Capital Management LLC grew its stake in National HealthCare by 1.7% during the first quarter. AQR Capital Management LLC now owns 16,080 shares of the company’s stock valued at $1,492,000 after acquiring an additional 262 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in National HealthCare by 3.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,247 shares of the company’s stock valued at $858,000 after acquiring an additional 281 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in National HealthCare by 7.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 73,772 shares of the company’s stock valued at $6,846,000 after acquiring an additional 4,879 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in National HealthCare by 18.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 30,246 shares of the company’s stock valued at $2,807,000 after acquiring an additional 4,628 shares during the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at National HealthCare

In other National HealthCare news, Director Lisa Piercey purchased 949 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was purchased at an average price of $184.26 per share, with a total value of $174,862.74. Following the acquisition, the director owned 949 shares in the company, valued at approximately $174,862.74. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 13.92% of the company’s stock.

National HealthCare Stock Performance

Shares of NHC opened at $223.59 on Friday. The company’s fifty day moving average is $212.50 and its 200 day moving average is $184.22. National HealthCare Corporation has a fifty-two week low of $105.50 and a fifty-two week high of $232.67. The stock has a market capitalization of $3.50 billion, a PE ratio of 25.15 and a beta of 0.61.

National HealthCare (NYSEAMERICAN:NHC) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.74 earnings per share (EPS) for the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%. The company had revenue of $408.03 million for the quarter.

National HealthCare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Wednesday, September 30th. National HealthCare’s dividend payout ratio is currently 61.89%.

Wall Street Analyst Weigh In

Several brokerages have commented on NHC. Royal Bank Of Canada upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. BMO Capital Markets raised National HealthCare to a “hold” rating in a report on Monday, May 18th. Robert W. Baird upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, The Goldman Sachs Group raised National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Two investment analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, National HealthCare has a consensus rating of “Buy”.

National HealthCare Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.